Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Baum

Showing results (21-30 of 143) with videos related to

Pageof 15
Sort By:
Current Gene Therapy|December 17, 2008
Clinical application of lentiviral vectors - concepts and practiceAxel Schambach, Christopher Baum
Acta Haematologica|October 30, 2003
Gene therapy targeting hematopoietic cells: better not leave it to chanceChristopher Baum, Christof von Kalle
Science (New York, N.Y.)|October 18, 2003
Medicine. Gene therapy--new challenges aheadDavid A Williams, Christopher Baum
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 4, 2011
Solving the problem of γ-retroviral vectors containing long terminal repeatsDerek A Persons, Christopher Baum
Best Practice & Research. Clinical Haematology|October 23, 2004
Safety and efficacy in retrovirally modified haematopoietic cell therapyZhixiong Li, Ute Modlich, Christopher Baum
Methods in Molecular Biology (Clifton, N.J.)|January 9, 2013
Retrovirus-based mRNA transfer for transient cell manipulationMelanie Galla, Axel Schambach, Christopher Baum
Annals of the New York Academy of Sciences|June 17, 2005
Control of self-renewal and differentiation of hematopoietic stem cells: HOXB4 on the thresholdHannes Klump, Bernhard Schiedlmeier, Christopher Baum
Seminars in Cancer Biology|July 6, 2010
The genomic risk of somatic gene therapyOlga Kustikova, Martijn Brugman, Christopher Baum
Current Gene Therapy|September 1, 2012
Retroviral protein transfer: falling apart to make an impactTobias Maetzig, Christopher Baum, Axel Schambach
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
Retroviral integration site analysis in hematopoietic stem cellsOlga S Kustikova, Christopher Baum, Boris Fehse
Pageof 15

Showing results (21-30 of 143) with videos related to

Sort By:
Pageof 15
Current Gene Therapy|December 17, 2008
Clinical application of lentiviral vectors - concepts and practiceAxel Schambach, Christopher Baum
Acta Haematologica|October 30, 2003
Gene therapy targeting hematopoietic cells: better not leave it to chanceChristopher Baum, Christof von Kalle
Science (New York, N.Y.)|October 18, 2003
Medicine. Gene therapy--new challenges aheadDavid A Williams, Christopher Baum
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 4, 2011
Solving the problem of γ-retroviral vectors containing long terminal repeatsDerek A Persons, Christopher Baum
Best Practice & Research. Clinical Haematology|October 23, 2004
Safety and efficacy in retrovirally modified haematopoietic cell therapyZhixiong Li, Ute Modlich, Christopher Baum
Methods in Molecular Biology (Clifton, N.J.)|January 9, 2013
Retrovirus-based mRNA transfer for transient cell manipulationMelanie Galla, Axel Schambach, Christopher Baum
Annals of the New York Academy of Sciences|June 17, 2005
Control of self-renewal and differentiation of hematopoietic stem cells: HOXB4 on the thresholdHannes Klump, Bernhard Schiedlmeier, Christopher Baum
Seminars in Cancer Biology|July 6, 2010
The genomic risk of somatic gene therapyOlga Kustikova, Martijn Brugman, Christopher Baum
Current Gene Therapy|September 1, 2012
Retroviral protein transfer: falling apart to make an impactTobias Maetzig, Christopher Baum, Axel Schambach
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
Retroviral integration site analysis in hematopoietic stem cellsOlga S Kustikova, Christopher Baum, Boris Fehse
Pageof 15